User profiles for Chandrali Bhattacharya

CHANDRALI S BHATTACHARYA

AstraZeneca
Verified email at astrazeneca.com
Cited by 99

Role of antibodies in diagnosis and treatment of ovarian cancer: Basic approach and clinical status

…, I Vhora, S Patil, J Amrutiya, C Bhattacharya… - Journal of controlled …, 2016 - Elsevier
Ovarian cancer is the second most leading gynecological cancer after endometrial cancer in
women. Chemotherapy and cyto-reductive surgery are currently the mainstays for treatment …

Comparison of in vitro stereoselective metabolism of bupropion in human, monkey, rat, and mouse liver microsomes

C Bhattacharya, D Kirby, M Van Stipdonk… - European journal of …, 2019 - Springer
Background and Objectives Bupropion is an atypical antidepressant and smoking cessation
aid associated with wide intersubject variability. This study compared the formation kinetics …

Population model analysis of chiral inversion and degradation of bupropion enantiomers, and application to enantiomer specific fraction unbound determination in rat …

C Bhattacharya, AR Masters, C Bach… - … of pharmaceutical and …, 2021 - Elsevier
Pharmacologic effects elicited by drugs most directly relate to their unbound concentrations.
Measurement of binding in blood, plasma and target tissues are used to estimate these …

Application of accelerator mass spectrometry to characterize the mass balance recovery and disposition of AZD4831, a novel myeloperoxidase inhibitor, following …

C Bhattacharya, AS Sandinge, RA Bragg… - Drug Metabolism and …, 2023 - ASPET
This study evaluated the mass balance and disposition of AZD4831, a novel myeloperoxidase
inhibitor, in six healthy participants using a 14 C-labeled microtracer coupled with …

Mass Balance and Absorption, Distribution, Metabolism, and Excretion Properties of Balcinrenone following Oral Administration in Combination with Intravenous …

B Lindmark, XQ Li, C Bhattacharya, G Housler… - Drug Metabolism and …, 2023 - ASPET
An absorption, distribution, metabolism, and excretion study was performed to determine the
basic pharmacokinetic parameters, mass balance, and metabolite profiles of balcinrenone, …

Characterization of the Stereoselective Disposition of Bupropion and Its Metabolites in Rat Plasma and Brain

CS Bhattacharya, AR Masters, C Bach, AL Sinn… - European Journal of …, 2023 - Springer
Background and Objectives Bupropion is an atypical antidepressant and smoking cessation
aid; its use is associated with wide intersubject variability in efficacy and safety. Knowledge …

Development of a Semimechanistic Pharmacokinetic-Pharmacodynamic Model Describing Dextroamphetamine Exposure and Striatal Dopamine Response in Rats …

…, JH Folgering, S Adhikari, C Bhattacharya… - … of Pharmacology and …, 2019 - ASPET
Acute central nervous system exposure to dextroamphetamine (d-amphetamine) elicits a
multitude of effects, including dual action on the dopamine transporter (DAT) to increase …

[PDF][PDF] Mass Balance and ADME Properties of Balcinrenone Following Oral Administration in Combination with Intravenous Microtracer in Healthy Subjects

B Lindmark, XQ Li, C Bhattacharya… - Drug Metabolism and …, 2023 - researchgate.net
An absorption, distribution, metabolism, and excretion study was performed to determine the
basic pharmacokinetic parameters, mass balance, and metabolite profiles of balcinrenone, …

Measurement of Stereoselective Bupropion Disposition in Rat Brain to Support Translational PBPK/PD Model Development and Application

CS Bhattacharya - 2020 - search.proquest.com
Background: Bupropion, an atypical antidepressant and smoking cessation aid, is associated
with wide inter-subject variability in its efficacy and safety. Variability in response to …

Mechanism-Based Pharmacokinetic-Pharmacodynamic Model Describing Dextroamphetamine Exposure and Striatal Dopamine Response in Rats and Non-Human …

…, J Folgering, S Adhikari, C Bhattacharya… - … of Pharmacology and …, 2019 - ASPET
Acute CNS exposure to dextroamphetamine (D-amphetamine) elicits a multitude of effects,
including dual action on the dopamine transporter (DAT) to increase extracellular dopamine, …